J. Corey-Bloom

发表

CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology

B. Miller, G. Small, L. Thal, 2001 .

Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques

Anders M. Dale, Russell A. Poldrack, Diederick Stoffers, 2011, NeuroImage.

Alzheimer's disease and P300: review and evaluation of task and modality.

J. Polich, J. Corey-Bloom, 2005, Current Alzheimer research.

Total recognition discriminability in Huntington’s and Alzheimer’s disease

Paul E. Gilbert, D. Delis, D. Salmon, 2017, Journal of clinical and experimental neuropsychology.

Temporal order memory deficits prior to clinical diagnosis in Huntington’s disease

Paul E. Gilbert, J. Corey-Bloom, J. Goldstein, 2009, Journal of the International Neuropsychological Society.

Cholinergic dysfunction in diseases with Lewy bodies

L. Thal, M. Sabbagh, E. Masliah, 2000, Neurology.

Quantification of five neuropsychological approaches to defining mild cognitive impairment.

D. Delis, D. Salmon, M. Bondi, 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease

L. Thal, E. Masliah, J. Corey-Bloom, 2004, Neurology.

Proactive Selective Response Suppression Is Implemented via the Basal Ganglia

A. Aron, J. Corey-Bloom, Weidong Cai, 2013, The Journal of Neuroscience.

Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year

Wesley K. Thompson, Diederick Stoffers, Samar Hamza, 2011, Movement disorders : official journal of the Movement Disorder Society.

Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation

Diederick Stoffers, Samar Hamza, Dominic Holland, 2011, Movement disorders : official journal of the Movement Disorder Society.

Screening for dementia of the alzheimer type in the community: the utility of the Clock Drawing Test.

N Butters, D P Salmon, W C Wiederholt, 1996, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Inversion recovery UTE based volumetric myelin imaging in human brain using interleaved hybrid encoding

Adam C. Searleman, Yajun Ma, E. Chang, 2020, Magnetic resonance in medicine.

Ultrashort echo time (UTE) magnetic resonance imaging of myelin: technical developments and challenges.

Hyungseok Jang, Jiang Du, Roland R. Lee, 2020, Quantitative imaging in medicine and surgery.

Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology

Bruce L. Miller, Gary W. Small, Jeffrey L. Cummings, 2007 .

Actigraphy for the assessment of sleep measures in Parkinson's disease.

Loki Natarajan, Sonia Ancoli-Israel, Jody Corey-Bloom, 2013, Sleep.

Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease

Paul E. Gilbert, J. Corey-Bloom, J. Goldstein, 2007, Journal of clinical and experimental neuropsychology.

Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease.

S. Ancoli-Israel, Jennifer L Martin, J. Corey-Bloom, 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

ACTIGRAPHY FOR ASSESSMENT OF SLEEP IN PARKINSON’S DISEASE

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2013 .

CPAP IMPROVES SLEEP AND SLEEPINESS IN PARKINSON PATIENTS WITH SLEEP APNEA

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2013 .

Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type. Commentary

Y. Agid, B. Dubois, J. Corey-Bloom, 1998 .

DEMENTIA AND NORMAL AGEING

J. Corey-Bloom, 1994 .

Inversion recovery ultrashort echo time magnetic resonance imaging: A method for simultaneous direct detection of myelin and high signal demonstration of iron deposition in the brain - A feasibility study.

Vipul R Sheth, Shu-Juan Fan, Yajun Ma, 2017, Magnetic resonance imaging.

Volumetric imaging of myelin in vivo using 3D inversion recovery-prepared ultrashort echo time cones magnetic resonance imaging.

Adam C. Searleman, Shu-Juan Fan, Yajun Ma, 2020, NMR in biomedicine.

Inversion recovery zero echo time (IR-ZTE) imaging for direct myelin detection in human brain: a feasibility study.

Adam C. Searleman, Yajun Ma, E. Chang, 2020, Quantitative imaging in medicine and surgery.

Improved volumetric myelin imaging in human brain using 3D dual echo inversion recovery‐prepared UTE with complex echo subtraction

Yajun Ma, E. Chang, Jiang Du, 2019, Magnetic resonance in medicine.

Independent Student Project Title : Neuropathic Pain in Multiple Sclerosis

J. Corey-Bloom, Johnathan V. Tran, 2017 .

Myelin water imaging using a short‐TR adiabatic inversion‐recovery (STAIR) sequence

Yajun Ma, G. Bydder, J. Corey-Bloom, 2022, Magnetic resonance in medicine.

Treatment trials in aging and mild cognitive impairment.

J. Corey-Bloom, 2012, Current topics in behavioral neurosciences.

The effect of interference on temporal order memory in premanifest and manifest Huntington's disease.

Paul E. Gilbert, J. Corey-Bloom, P. Gilbert, 2013, Journal of Huntington's disease.

Handwriting Movement Abnormalities in Symptomatic and Premanifest Huntington's Disease

J. Corey-Bloom, M. Caligiuri, Chase M. Snell, 2019, Movement disorders clinical practice.

Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease.

Paul E. Gilbert, J. Corey-Bloom, P. Gilbert, 2016, Journal of Huntington's disease.

The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease

Paul E. Gilbert, J. Corey-Bloom, P. Gilbert, 2022, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Associations between prognostic index scores and plasma neurofilament light in Huntington's disease.

J. Long, J. Corey-Bloom, G. Parkin, 2022, Parkinsonism & related disorders.

The spectrum of diseases with diffuse Lewy bodies.

L. Thal, D. Galasko, J. Corey-Bloom, 1995, Advances in neurology.

Weight loss precedes dementia in community-dwelling older adults.

E. Barrett-Connor, J. Corey-Bloom, W. Wiederholt, 1996, Journal of the American Geriatrics Society.

Adjunctive Therapy in Patients with Alzheimer’s Disease

D. Galasko, J. Corey-Bloom, 1995, Drugs & aging.

Volumetric Imaging of Myelin in vivo Using 3D Inversion-Recovery Ultrashort Echo Time Cones Magnetic Resonance Imaging

Adam C. Searleman, Shu-Juan Fan, Yajun Ma, 2021 .

Leptomeningeal Metastases.

J. Corey-Bloom, M. Chamberlain, Zachary A. Corbin, 2016, JAMA oncology.

Measurement of T1 of the T2* components in white matter of the brain at 3T.

Vipul R Sheth, G. Bydder, Jiang Du, 2014 .

Seizures in juvenile Huntington's disease: Frequency and characterization in a multicenter cohort

Jagan A. Pillai, C. Ross, J. Corey-Bloom, 2012, Movement disorders : official journal of the Movement Disorder Society.

Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease

H. D. Rosas, R. Reilmann, N. Svrzikapa, 2020, Neurology: Genetics.

Salivary Huntingtin protein is uniquely associated with clinical features of Huntington’s disease

J. Corey-Bloom, A. Bresciani, Elizabeth A. Thomas, 2023, Scientific Reports.

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Kimberly A. Walters, L. Seeberger, L. Raymond, 2022, Nature Medicine.

Plasma neurofilament light in Huntington’s disease: A marker for disease onset, but not symptom progression

J. Corey-Bloom, E. Thomas, Chase M. Snell, 2021, Parkinsonism & related disorders.

Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease

Paul E. Gilbert, J. Corey-Bloom, J. Goldstein, 2013, Movement disorders : official journal of the Movement Disorder Society.

Cognitive Performance on the Mini-Mental State Examination and the Montreal Cognitive Assessment Across the Healthy Adult Lifespan

J. Corey-Bloom, J. Goldstein, Kiet Loc, 2013, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Repeated exposure to the Mini‐Mental State Examination and the Information‐Memory‐Concentration Test results in a practice effect in Alzheimer's disease

L. Thal, D. Galasko, J. Corey-Bloom, 1993, Neurology.

Salivary levels of total huntingtin are elevated in Huntington’s disease patients

J. Corey-Bloom, E. Thomas, Sungmee Park, 2018, Scientific Reports.

The importance of neuritic plaques and tangles to the development and evolution of AD

L A Hansen, L. Thal, J. Corey-Bloom, 2004, Neurology.

Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotation

D. Salmon, M. Bondi, J. Corey-Bloom, 2005, Journal of the International Neuropsychological Society.

The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease.

Paul E. Gilbert, J. Corey-Bloom, E. Breen, 2015, Journal of neuropsychology.

Longitudinal Changes in Cognition

L. Thal, D. Galasko, J. Corey-Bloom, 1994 .

Weight Loss Precedes Dementia in Community‐Dwelling Older Adults

E. Barrett-Connor, J. Corey-Bloom, W. Wiederholt, 1996, The journal of nutrition, health & aging.

Alzheimer disease without neocortical neurofibrillary tangles

L. Thal, D. Salmon, M. Sabbagh, 2004, Neurology.

Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

J. Corey-Bloom, E. Thomas, Paula A. Desplats, 2020, Frontiers in Molecular Neuroscience.

Brain ultrashort T2 component imaging using a short TR adiabatic inversion recovery prepared dual-echo ultrashort TE sequence with complex echo subtraction (STAIR-dUTE-ES).

Yajun Ma, E. Chang, G. Bydder, 2020, Journal of magnetic resonance.

Myelin Imaging in Human Brain Using a Short Repetition Time Adiabatic Inversion Recovery Prepared Ultrashort Echo Time (STAIR-UTE) MRI Sequence in Multiple Sclerosis.

Roland R. Lee, Yajun Ma, E. Chang, 2020, Radiology.

Whole-Brain Myelin Imaging Using 3D Double-Echo Sliding Inversion Recovery Ultrashort Echo Time (DESIRE UTE) MRI.

Adam C. Searleman, Yajun Ma, E. Chang, 2019, Radiology.

Measurement of T1 of the Ultrashort T2* Components in White Matter of the Brain at 3T

Jiang Du, Jun Chen, Graeme M. Bydder, 2014, PloS one.

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

A. Gamst, J. Corey-Bloom, T. Wolfson, 2012, Canadian Medical Association Journal.

The natural history of Alzheimer’s disease

Michael S. Rafii, Jody Corey-Bloom, J. Corey-Bloom, 2017 .

Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment.

M. Bondi, C. Wierenga, J. Corey-Bloom, 2009, International review of neurobiology.

Quantitative magnetic resonance imaging of the brain in late-life schizophrenia.

M J Harris, D. Jeste, T. Jernigan, 1995, The American journal of psychiatry.

Differences in body sway can be identified in Huntington's disease using a practical balance assessment device.

Paul E. Gilbert, J. Corey-Bloom, D. Goble, 2022, Parkinsonism & related disorders.

Stability of resting fMRI interregional correlations analyzed in subject-native space: A one-year longitudinal study in healthy adults and premanifest Huntington's disease

James B. Brewer, Adam R. Aron, Tyler M. Seibert, 2012, NeuroImage.

Impaired postural stability as a marker of premanifest Huntington's disease

Paul E. Gilbert, Jody Corey-Bloom, Roger Simmons, 2010, Movement disorders : official journal of the Movement Disorder Society.

Contrasting gray and white matter changes in preclinical Huntington disease

A. Aron, J. Corey-Bloom, D. Stoffers, 2010, Neurology.

Identifying the “source” of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: Evidence from the CVLT-II

D. Delis, D. Salmon, M. Bondi, 2008, Journal of clinical and experimental neuropsychology.

E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease

E. Masliah, J. Corey-Bloom, P. Tiraboschi, 2000, Neurology.

Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer’s disease

L. Thal, M. Sabbagh, J. Corey-Bloom, 2000, Neurobiology of Aging.

Clinical severity of Huntington's disease does not always correlate with neuropathologic stage

Jagan A. Pillai, E. Masliah, J. Corey-Bloom, 2012, Movement disorders : official journal of the Movement Disorder Society.

In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease

Jane S. Paulsen, D P Salmon, D. Salmon, 2004, Neurology.

Behavioural abnormalities contribute to functional decline in Huntington’s disease

Jane S. Paulsen, D. Salmon, A. Gamst, 2003, Journal of neurology, neurosurgery, and psychiatry.

Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.

L. Thal, J. Corey-Bloom, M. Grundman, 1998, Journal of neural transmission. Supplementum.

Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses.

D. Jeste, T. Jernigan, J. Corey-Bloom, 1997, The Journal of neuropsychiatry and clinical neurosciences.

Detection of dementia of the Alzheimer type in a population-based sample: Neuropsychological test performance

N Butters, D P Salmon, W C Wiederholt, 1995, Journal of the International Neuropsychological Society.

A randomized, placebo-controlled trial of latrepirdine in Huntington disease.

J. Corey-Bloom, E. Dorsey, S. Factor, 2010, Archives of neurology.

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

D. Jeste, L. Thal, D. Galasko, 2003, Neurology.

Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer’s Disease

S. Ancoli-Israel, J. Corey-Bloom, M. Marler, 2006, Drugs & aging.

Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response

Lisa T. Eyler, Amy J. Jak, Adam S. Fleisher, 2007, Neurobiology of Aging.

Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment

M. Bondi, J. Corey-Bloom, K. Bangen, 2009, Journal of the International Neuropsychological Society.

Development and Psychometric Properties of a New Brief, Yet Comprehensive, Behavioral Questionnaire for Huntington's Disease

Paul E. Gilbert, J. Corey-Bloom, V. Malcarne, 2023, Movement disorders clinical practice.

The contribution of cognition and spasticity to driving performance in multiple sclerosis.

R Wade Allen, Jody Corey-Bloom, Theodore J Rosenthal, 2008, Archives of physical medicine and rehabilitation.

Identification of Subtle Verbal Memory Deficits in Premanifest Huntington Disease Using the California Verbal Learning Test

Paul E. Gilbert, D. Delis, J. Corey-Bloom, 2020, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Obstructive Sleep Apnea and Cognition in Parkinson's disease.

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2016, Sleep medicine.

Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study.

Loki Natarajan, Sonia Ancoli-Israel, Liat Ayalon, 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Cognitive Effects of Treating Obstructive Sleep Apnea in Alzheimer's Disease: A Randomized Controlled Study

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2008, Journal of the American Geriatrics Society.

Effect of light on agitation in institutionalized patients with severe Alzheimer disease.

S. Ancoli-Israel, Jennifer L Martin, J. Corey-Bloom, 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea.

S. Ancoli-Israel, J. Corey-Bloom, C. Stepnowsky, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy

L. Thal, T. Jernigan, J. Corey-Bloom, 1996, Neurology.

Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2013, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer's Disease Patients

Sonia Ancoli-Israel, Jody Corey-Bloom, S. Ancoli-Israel, 2003, Behavioral sleep medicine.

The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease

L. Thal, E. Masliah, J. Corey-Bloom, 2000, Neurology.

Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease.

L. Thal, M. Sabbagh, E. Masliah, 1999, Archives of neurology.

Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease

L. Thal, M. Sabbagh, E. Masliah, 1998, Journal of Neural Transmission.

Hippocampal Sclerosis Contributes to Dementia in the Elderly

L. Thal, M. Bondi, M. Sabbagh, 1997, Neurology.

Source recognition discriminability impairment in Huntington's versus Alzheimer's disease: Evidence from the CVLT-3.

Paul E. Gilbert, D. Delis, D. Salmon, 2022, Applied neuropsychology. Adult.

New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer’s and Huntington’s Disease

Paul E. Gilbert, D. Delis, D. Salmon, 2018, Journal of the International Neuropsychological Society.

Revisiting total recognition discriminability in Huntington’s and Alzheimer’s disease: New insights from the CVLT-3

Paul E. Gilbert, D. Delis, D. Salmon, 2019, Applied neuropsychology. Adult.

“Forgetting to Remember” in Huntington's Disease: A Study of Laboratory, Semi-Naturalistic, and Self-Perceptions of Prospective Memory

Paul E. Gilbert, J. Filoteo, J. Corey-Bloom, 2013, Journal of the International Neuropsychological Society.

What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?

L. Thal, D. Salmon, J. Corey-Bloom, 2006, Brain : a journal of neurology.

Neuropsychological deficits associated with Alzheimer's disease in the very-old: Discrepancies in raw vs. standardized scores

D. Delis, L. Thal, D. Salmon, 2003, Journal of the International Neuropsychological Society.

Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.

L. Thal, E. Masliah, J. Corey-Bloom, 2002, Archives of general psychiatry.

Safety and Tolerability of Donepezil at Doses up to 20 mg/day

R. Doody, J. Corey-Bloom, R. Schindler, 2008, Drugs & aging.

Central Cognitive Processing Speed Is an Early Marker of Huntington's Disease Onset

Paul E. Gilbert, J. Corey-Bloom, Brenton A Wright, 2020, Movement disorders clinical practice.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

L. Seeberger, L. Raymond, R. Barker, 2013, JAMA neurology.

Clinical correlates of periodic limb movements in sleep in Parkinson's disease

S. Ancoli-Israel, J. Corey-Bloom, B. Palmer, 2012, Journal of the Neurological Sciences.

Rate and correlates of weight change in Huntington’s disease*

J. Corey-Bloom, T. Wolfson, G. Peavy, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Clinical Adult Neurology

J. Corey-Bloom, R. David, 2008 .

Cognitive and functional decline in Huntington's disease: Dementia criteria revisited

A. Gamst, J. Corey-Bloom, J. Goldstein, 2010, Movement disorders : official journal of the Movement Disorder Society.

Diagnostic accuracy of dementia with Lewy bodies.

L. Thal, J. Corey-Bloom, P. Tiraboschi, 2000, Archives of neurology.

Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2014, Sleep medicine.

Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2014, Sleep.

Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2012, Autonomic Neuroscience.

The signal intensity variation of multiple sclerosis (MS) lesions on magnetic resonance imaging (MRI) as a potential biomarker for patients’ disability: A feasibility study

J. Corey-Bloom, H. Jang, S. Sedaghat, 2023, Frontiers in Neuroscience.

The ABC of Alzheimer's Disease: Cognitive Changes and Their Management in Alzheimer's Disease and Related Dementias

J. Corey-Bloom, 2002, International Psychogeriatrics.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Jane S. Paulsen, Megan M. Romer, J. Jankovic, 2016, JAMA neurology.

Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies

Jun Chen, Graeme M. Bydder, Vipul Sheth, 2016, NeuroImage.

Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner

Nikolaus M. Szeverenyi, Graeme M. Bydder, Michael Carl, 2014, NeuroImage.

Differential Cross-Sectional and Longitudinal Impact of APOE Genotype on Hippocampal Volumes in Nondemented Older Adults

Amy J. Jak, Wes S. Houston, Bonnie J. Nagel, 2007, Dementia and Geriatric Cognitive Disorders.

Spongiform Change in Dementia With Lewy Bodies and Alzheimer Disease

E. Masliah, J. Corey-Bloom, S. Edland, 2013, Alzheimer disease and associated disorders.

The timing of activity rhythms in patients with dementia is related to survival.

S. Ancoli-Israel, Jennifer L Martin, J. Corey-Bloom, 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington’s Disease Patients and Healthy Control Subjects

J. Corey-Bloom, D. Granger, S. Granger, 2020, International journal of molecular sciences.

Recall and Recognition Discriminability in Parkinson's Disease and Huntington's Disease.

Paul E. Gilbert, D. Delis, J. Corey-Bloom, 2019, Journal of Huntington's disease.

Recall discriminability: Utility of a new CVLT–II measure in the differential diagnosis of dementia

Jody Corey-Bloom, Assawin Gongvatana, Dean C Delis, 2005, Journal of the International Neuropsychological Society.

Clinical Features Distinguishing Large Cohorts with Possible AD, Probable AD, and Mixed Dementia

L. Thal, D. Galasko, J. Corey-Bloom, 1993, Journal of the American Geriatrics Society.

“SENILITY” REDEFINED AS AGE‐ASSOCIATED FRONTAL SYSTEM IMPAIRMENT?

D. Royall, J. Corey-Bloom, M. Polk, 1997, Journal of the American Geriatrics Society.

Everyday Functioning in Huntington’s Disease: A Laboratory-Based Study of Financial Management Capacity

Paul E. Gilbert, J. Filoteo, J. Corey-Bloom, 2017, Applied neuropsychology. Adult.

Diagnosis and evaluation of dementia*

L. Thal, M. Folstein, D. Drachman, 1995, Neurology.

Changes on brief cognitive instruments over time in Parkinson's disease

J. Corey-Bloom, S. Lessig, Dong Nie, 2012, Movement disorders : official journal of the Movement Disorder Society.

The relationship between dementia severity and rest/activity circadian rhythms

S. Ancoli-Israel, Jennifer L Martin, J. Corey-Bloom, 2005, Neuropsychiatric disease and treatment.

Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

D. Connor, S. Ancoli-Israel, Jennifer L Martin, 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Monitoring Progression in Alzheimer's Disease

L. Thal, J. Corey-Bloom, Douglas Galasko, 1991, Journal of the American Geriatrics Society.

Cognitive and Functional Status of the Oldest Old

D. Salmon, E. Barrett-Connor, J. Corey-Bloom, 1996, Journal of the American Geriatrics Society.

Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy

Paul E. Gilbert, J. Corey-Bloom, C. McDonald, 2019, Applied neuropsychology. Adult.

The Effect of Sleep-Disordered Breathing on Stages of Sleep in Patients With Alzheimer's Disease

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2006, Behavioral sleep medicine.

Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease

J. Corey-Bloom, H. Brodaty, M. Gold, 2005, Dementia and Geriatric Cognitive Disorders.

Continuous Positive Airway Pressure Reduces Subjective Daytime Sleepiness in Patients with Mild to Moderate Alzheimer's Disease with Sleep Disordered Breathing

S. Ancoli-Israel, J. Corey-Bloom, M. Marler, 2006, Journal of the American Geriatrics Society.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

R. Reilmann, K. Marder, J. Corey-Bloom, 2019, The Lancet Neurology.

Inversion Recovery Ultrashort TE MR Imaging of Myelin is Significantly Correlated with Disability in Patients with Multiple Sclerosis

E. Chang, G. Bydder, J. Corey-Bloom, 2021, American Journal of Neuroradiology.

New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer’s versus Huntington’s Disease

Paul E. Gilbert, D. Delis, D. Salmon, 2019, Journal of the International Neuropsychological Society.

Postural deficits in Huntington's disease when performing motor skills involved in daily living.

Paul E. Gilbert, J. Corey-Bloom, J. Goldstein, 2011, Gait & posture.

Postural limits of stability in premanifest and manifest Huntington's disease.

Paul E. Gilbert, Jody Corey-Bloom, Roger Simmons, 2013, Journal of Huntington's disease.

Abstracts from HSG 2019

Vita, D. Delis, J. Corey-Bloom, 2019, Neurotherapeutics.

Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea.

S. Ancoli-Israel, J. Corey-Bloom, L. Natarajan, 2009, Sleep medicine.

Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients

J. Corey-Bloom, D. Granger, S. Granger, 2020, Frontiers in Neuroscience.

Salivary levels of total huntingtin are elevated in Huntington’s disease patients

J. Corey-Bloom, E. Thomas, Sungmee Park, 2018, Scientific Reports.

Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment

Paul E. Gilbert, J. Corey-Bloom, J. Goldstein, 2016, American journal of Alzheimer's disease and other dementias.

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional study

J. Corey-Bloom, Elizabeth A. Thomas, Georgia M. Parkin, 2023, EBioMedicine.

A comparison of two brief screening measures of cognitive impairment in Huntington's disease

J. Wixted, J. Corey-Bloom, L. Mickes, 2010, Movement disorders : official journal of the Movement Disorder Society.

Beneficial effects of glatiramer acetate in Huntington’s disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms

J. Corey-Bloom, E. Thomas, Ashley M. Gutierrez, 2017, Brain Research.

Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease.

J. Corey-Bloom, E. Thomas, Haiqun Jia, 2014, Journal of Huntington's disease.

Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging

Paul E. Gilbert, D. Delis, M. Bondi, 2018, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Difficulty modifying a sustained motor response in prodromal Huntington's disease

J. Wixted, J. Corey-Bloom, L. Mickes, 2013, Journal of clinical and experimental neuropsychology.

Cognitive functioning in complicated grief.

B. Lebowitz, C. Reynolds, S. Zisook, 2014, Journal of psychiatric research.

Autonomic Sudomotor Dysfunction in Alzheimers Disease

M. Sabbagh, R. Doody, J. Corey-Bloom, 2003 .

Predictors of nursing home placement in Huntington disease

Kathleen N. Francis, L. Seeberger, L. Raymond, 2003, Neurology.

Behavioral Measures of Saccade Latency and Inhibition in Manifest and Premanifest Huntington's Disease

T. Turner, J. Corey-Bloom, J. Goldstein, 2011, Journal of motor behavior.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.

LASSI-L detects early cognitive changes in pre-motor manifest Huntington’s disease: a replication and validation study

Simon E. Laganiere, J. Corey-Bloom, M. Halko, 2023, Frontiers in neurology.

The emergence of age-related changes in recognition memory in healthy middle-aged adults using the CVLT-II

Paul E. Gilbert, D. Delis, M. Bondi, 2019, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

The Functional Implications of Motor, Cognitive, Psychiatric, and Social Problem-Solving States in Huntington's Disease

J. Corey-Bloom, J. Goldstein, Charles Van Liew, 2013, Psychiatry.

Behavioral Measures of Saccade Latency and Inhibition in Manifest and Premanifest Huntington's Disease

T. Turner, J. Corey-Bloom, J. Goldstein, 2011, Journal of Motor Behavior.

Journal of Clinical and Experimental Neuropsychology Difficulty Modifying a Sustained Motor Response in Prodromal Huntington's Disease

J. Wixted, J. Corey-Bloom, L. Mickes, 2022 .

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

A. Gamst, J. Corey-Bloom, T. Wolfson, 2012, Canadian Medical Association Journal.

Treatment trials in aging and mild cognitive impairment.

J. Corey-Bloom, 2012, Current topics in behavioral neurosciences.

The Vitamin D Metabolite Ratio (VMR) is a Biomarker of Vitamin D Status That is Not Affected by Acute Changes in Vitamin D Binding Protein.

J. Corey-Bloom, A. Hoofnagle, J. Ix, 2023, Clinical chemistry.

Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotation

D. Salmon, M. Bondi, J. Corey-Bloom, 2005, Journal of the International Neuropsychological Society.

Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy

Paul E. Gilbert, J. Corey-Bloom, C. McDonald, 2019, Applied neuropsychology. Adult.

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Simon E. Laganiere, Jamie L. Adams, L. Seeberger, 2023, The Lancet Neurology.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.

Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease.

Paul E. Gilbert, J. Corey-Bloom, M. Schmitter-Edgecombe, 2018, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Graphomotor Dysfluency as a Predictor of Disease Progression in Premanifest Huntington's Disease.

J. Corey-Bloom, Chase M. Snell, M. Caligiuri, 2023, Journal of Huntington's disease.